Atlas Trials

Congenital Hyperinsulinism

22 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Congenital Hyperinsulinism

RecordFirmDate
HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI) (NCT04732416)Hanmi Pharmaceutical Company Limited2022-05-05
18F-DOPA II - PET Imaging Optimization (NCT04706910)University of Alberta2021-01-20
Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism (NCT04172441)Zealand Pharma2020-06-19
Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism (NCT03941236)Zealand Pharma2019-05-02
A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism (NCT03777176)Zealand Pharma2019-02-07
GLP-1 Receptor Expression in CHI (NCT03768518)Radboud University Medical Center2018-02-07
18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety (NCT03042416)University of Alberta2017-06-29
Pasireotide in Hyperinsulinemic Hypoglycemia (NCT03053284)Montefiore Medical Center2017-04-01
18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism (NCT04205604)Miguel Pampaloni2016-11-03
CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism (NCT02937558)Xeris Pharmaceuticals2016-10-01
Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy (NCT01070758)Sheba Medical Center2010-02-01
Effect of Exendin (9-39) on Glucose Requirements to Maintain Euglycemia (NCT00835328)Diva De Leon2009-08-26
Sandostatine® LP and Hyperinsulinism (NCT00987168)Assistance Publique - Hôpitaux de Paris2009-05-01
Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity (NCT00897676)Diva De Leon2009-05-01
Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism (NCT00571324)Diva De Leon2007-08-01
Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism (NCT00674440)Children's Hospital of Philadelphia2004-12-01
Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia (NCT02835131)Montefiore Medical Center

Track Congenital Hyperinsulinism automatically

Every clearance here is in the API, with alerts when new ones post.